An expert writes about his experience as a sarcoma medical oncologist and how the field may progress with several therapies in the pipeline. As a sarcoma medical oncologist, the No. 1 question I am ...
Objective Response Rate (ORR) in Advanced Sarcomas Significant Market Opportunity with More than 8,000 Patients Diagnosed Annually in the U.S. and Europe SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE ...
When surgery is part of the treatment plan, choosing a team with deep sarcoma-specific surgical experience is one of the most important decisions a patient can make. With more than 70 distinct sarcoma ...
Now that you've gotten your diagnosis of liposarcoma, a type of cancer that starts in fat cells, it's time to learn how to best manage your doctor's visits and deal with treatment side effects. It's ...
At Huntsman Cancer Institute, you receive comprehensive, multidisciplinary care for organ-based sarcomas. Our Sarcoma Care Team provides personalized and compassionate care at every step, from ...
Rain Oncology is a late-stage oncology company. Their lead product, milademetan, is an oral inhibitor of the MDM2-p53. In the past, MDM2 inhibitors have been associated with severe hematologic events.
The field of sarcoma study is getting more specific, with clinical investigations drilling down to more specific subtypes of soft tissue sarcoma for better targeted therapies. Our discussion with ...
If you would like a patient care coordinator to reach out to you, please fill out our form to schedule an information call. Form: Schedule a Call with a Patient Care Coordinator Proton therapy is an ...
A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked ...
An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results